![Konstantin Bloch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Konstantin Bloch
Corporate Officer/Principal chez Felsenstein Medical Research Center
Postes actifs de Konstantin Bloch
Sociétés | Poste | Début | Fin |
---|---|---|---|
Felsenstein Medical Research Center | Corporate Officer/Principal | - | - |
Historique de carrière de Konstantin Bloch
Anciens postes connus de Konstantin Bloch
Sociétés | Poste | Début | Fin |
---|---|---|---|
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | - | - |
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Fondateur | 01/01/2004 | - |
Formation de Konstantin Bloch
Kharkiv National University | Undergraduate Degree |
Russian Academy of Sciences | Doctorate Degree |
Statistiques
Internationale
Israël | 4 |
Ukraine | 2 |
Russie | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Founder | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Health Technology |
Felsenstein Medical Research Center |
- Bourse
- Insiders
- Konstantin Bloch
- Expérience